Cargando…
Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects
Gastric cancer presents substantial management challenges, and the advent of immunotherapy has ignited renewed hope among patients. Nevertheless, a significant proportion of patients do not respond to immunotherapy, and adverse events associated with immunotherapy also occur on occasion, underscorin...
Autores principales: | Hou, Wanting, Zhao, Yaqin, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607383/ https://www.ncbi.nlm.nih.gov/pubmed/37895000 http://dx.doi.org/10.3390/ijms242015321 |
Ejemplares similares
-
Predictive biomarkers of colon cancer immunotherapy: Present and future
por: Hou, Wanting, et al.
Publicado: (2022) -
Biomarkers for Predicting Response to Personalized Immunotherapy in Gastric Cancer
por: Kim, Moonsik, et al.
Publicado: (2023) -
Current Status and Prospects of Immunotherapy for Gynecologic Melanoma
por: Anko, Mayuka, et al.
Publicado: (2021) -
Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
por: Hazama, Shoichi, et al.
Publicado: (2018) -
Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020)